Clinuvel Pharmaceuticals Ltd (CLVLY)
9.040
+0.09
(+1.00%)
USD |
OTCM |
Nov 14, 15:17
Clinuvel Pharmaceuticals Shareholders Equity (Quarterly): 135.69M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 135.69M |
December 31, 2023 | 121.71M |
June 30, 2023 | 108.97M |
December 31, 2022 | 94.68M |
June 30, 2022 | 86.37M |
December 31, 2021 | 77.78M |
June 30, 2021 | 74.19M |
December 31, 2020 | 60.04M |
June 30, 2020 | 50.62M |
December 31, 2019 | 40.62M |
June 30, 2019 | 40.05M |
December 31, 2018 | 30.38M |
June 30, 2018 | 28.95M |
December 31, 2017 | 21.33M |
June 30, 2017 | 19.51M |
December 31, 2016 | 14.80M |
June 30, 2016 | 13.29M |
December 31, 2015 | 6.356M |
June 30, 2015 | 8.594M |
December 31, 2014 | 10.46M |
June 30, 2014 | 14.53M |
December 31, 2013 | 9.689M |
June 30, 2013 | 12.84M |
Date | Value |
---|---|
December 31, 2012 | 10.13M |
June 30, 2012 | 13.68M |
December 31, 2011 | 11.17M |
June 30, 2011 | 17.54M |
December 31, 2010 | 22.41M |
June 30, 2010 | 22.22M |
December 31, 2009 | 29.57M |
June 30, 2009 | 29.86M |
December 31, 2008 | 30.01M |
June 30, 2008 | 49.62M |
December 31, 2007 | 51.45M |
June 30, 2007 | 55.43M |
December 31, 2006 | 34.95M |
June 30, 2006 | 10.38M |
December 31, 2005 | 10.13M |
June 30, 2005 | 5.679M |
December 31, 2004 | 10.67M |
June 30, 2004 | 6.170M |
December 31, 2003 | 8.988M |
June 30, 2003 | 5.067M |
December 31, 2002 | 4.735M |
June 30, 2002 | 5.804M |
December 31, 2001 | 6.087M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
40.62M
Minimum
Dec 2019
135.69M
Maximum
Jun 2024
85.07M
Average
82.07M
Median
Shareholders Equity (Quarterly) Benchmarks
Alterity Therapeutics Ltd | 26.42M |
Kazia Therapeutics Ltd | 3.589M |
Immutep Ltd | 22.88M |
Opthea Ltd | -75.81M |
Mesoblast Ltd | 501.84M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 154.48M |
Total Liabilities (Quarterly) | 18.79M |
Current Ratio | 8.808 |
Net Debt Paydown Yield | 0.05% |